220
Participants
Start Date
July 31, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
Mebeverine
Subjects treated by Duspatalin (mebeverine) 200 mg BID (bis in die = twice a day) upto 6 weeks in accordance with routine practice will be observed
Research facility ID ORG-001039, Moscow
"Federal State Budget Institution Outpatient hospital №1 Administration of the President of the Russian Federation", Moscow
"State Budget Institution Pirogov Russian National Research Medical University, on the base of State Budget Institution of Health Care of Moscow City Clinical Hospital №31", Moscow
"State Budget Institution Russian Medical Academy of Postgraduate Studies", Moscow
"State Budget Institution of Health Care of Moscow region MF Vladimirsky Moscow Region Scientific Research Clinical University", Moscow
Research Facility ID ORG-001024, Moscow
Federal State Budget Institution All-Russian Center of Emergency and Radiation Medicine of EMERCOM of Russia, Saint Petersburg
"State Budget Institution North-Western State Medical University named after I.I. Mechnikov, on the base of State Budget Institution Sity Clinical Hospital #26", Saint Petersburg
Research Facility ID ORG-001036, Rostov-on-Don
Research Facility ID ORG-001033, Kazan'
Research Facility ID ORG-001038, Izhevsk
Research Facility ID ORG-001037, Saransk
"State Budget Institution Nizhny Novgorod Regional Clinical Hospital n.a. Semashko", Nizhny Novgorod
Research Facility ID ORG-000903, Omsk
Research Facility ID ORG-001034, Krasnoyarsk
"State Budget Institution Irkutsk State Medical Academy of postgraduate education", Irkutsk
Research Facility ID ORG-001035, Chita
"Non-governmental Healthcare Institution Road Clinical Hospital on the station Khabarovsk-1 OSS Russian Railways", Khabarovsk
"State Budget Institution Novosibirsk State Medical University", Novosibirsk
Federal State Budget Institution Hospital of the Pushchino Scientific Center of the Russian Academy of Sciences, Pushino
City Clinical Hospital #40, Yekaterinburg
Lead Sponsor
Abbott
INDUSTRY